Estudo comparativo das complicações terapêuticas no Lúpus Eritematoso Sistêmico e nas glomerulopatias idiopáticas.
Alternative titleA comparative study of therapeutic complications in Systemic Lupus Erythematosus and in idiopathic glomerulopathy
MetadataShow full item record
PURPOSE: To evaluate the therapeutic complications due to the use of immunosupressors in patients with nephropathy. METHODS: 76 patients who had used steroids and cyclophosphamide were retrospectively studied. The cases were divided into three groups: G1= 15 patients with Systemic Lupus Erythematosus without renal lesion; G2= 33 patients with lupus nephritis and G3= 28 patients with nephrotic syndrome owing to idiopathic glomerulopathy. RESULTS: There were no differences related to time of follow up (G1= 42.4 +/- 51, G2= 52.3 +/- 51, G3= 41.8 +/- 47.8 months), total used dosage of steroids (G1= 20, G2= 28, G3= 16 grams) and time of drug use (G1= 20, G2= 26, G3= 14.5 months). About cyclophosphamide use, there was no difference in the percentage of patients who used it (13% in G1, 51% in G2, 28% in G3), but the patients from G1 received lower total dosage than those from G2 (p<0.05). Cushingoid appearance, epigastric distress, psychiatric disorders, diabetes mellitus and ocular alterations occurred in all the three groups, with no statistically significant differences. The infections complications, those considered more severe clinically, were more frequent in G2 (G1= 6%, G2= 15%, G3= 0% - p<0.05), the same occurring with the deaths (7% in G1, 30% in G2, 0% in G3 - p<0.05). CONCLUSION: In patients with lupus nephritis there were more infections complications owing to prolonged immunosuppresion what may indicate a severity marker of this type of lesion.
How to cite this document
Showing items related by title, author, creator and subject.
Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus Sato, J. O. ; Corrente, J. E. ; Saad-Magalhães, C. (Lupus, 2016) [Artigo]Objective The objective of this study was to assess Modified Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and European Consensus Lupus Activity Measurement (ECLAM) disease activity correlation in ...
Correlation between the european consensus lupus activity measurement (ECLAM) and the modified systemic lupus erythematosus disease activity index 2000 (M-SLEDAI 2k) in juvenile systemic lupus erythematosus (JSLE) Sato, Juliana de Oliveira ; Corrente, José Eduardo ; Magalhães, Cláudia Saad (Annals Of The Rheumatic Diseases, 2014) [Resumo]
Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus Novak, Glaucia V.; Marques, Mariana; Balbi, Verena; Gormezano, Natali W.S.; Kozu, Kátia; Sakamoto, Ana P.; Pereira, Rosa M.R.; Terreri, Maria T.; Magalhães, Claudia S. ; Guariento, Andressa et al. (Autoimmunity Reviews, 2017) [Resenha]Background To our knowledge there are no studies assessing anti-Ro/SSA and anti-La/SSB autoantibodies in a large population of childhood-systemic lupus erythematosus (cSLE) patients. Methods This was a retrospective ...